BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 20679879)

  • 1. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
    Hughes NR; Goodman ZD; Bhathal PS
    Am J Surg Pathol; 2010 Sep; 34(9):1312-8. PubMed ID: 20679879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
    Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
    J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The so-called bile duct adenoma is a peribiliary gland hamartoma.
    Bhathal PS; Hughes NR; Goodman ZD
    Am J Surg Pathol; 1996 Jul; 20(7):858-64. PubMed ID: 8669534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma.
    Albores-Saavedra J; Chablé-Montero F; Méndez-Sánchez N; Mercado MÁ; Vilatoba-Chapa M; Henson DE
    Hum Pathol; 2012 Dec; 43(12):2292-8. PubMed ID: 22795356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
    Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
    Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary neoplasm arising from peribiliary glands connecting with the inferior branch of the bile duct of the anterior segment of the liver.
    Nakanishi Y; Nakanuma Y; Ohara M; Iwao T; Kimura N; Ishidate T; Kijima H
    Pathol Int; 2011 Dec; 61(12):773-7. PubMed ID: 22126388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile duct adenoma and von Meyenburg complex-like duct arising in hepatitis and cirrhosis: pathogenesis and histological characteristics.
    Aishima S; Tanaka Y; Kubo Y; Shirabe K; Maehara Y; Oda Y
    Pathol Int; 2014 Nov; 64(11):551-9. PubMed ID: 25329860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human fetal ductal plate revisited: II. MUC1, MUC5AC, and MUC6 are expressed in human fetal ductal plate and MUC1 is expressed also in remodeling ductal plate, remodeled ductal plate and mature bile ducts of human fetal livers.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):571-85. PubMed ID: 23573304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
    Sirica AE; Radaeva S; Caran N
    Am J Pathol; 1997 Dec; 151(6):1685-94. PubMed ID: 9403719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.
    Elmore LW; Sirica AE
    Cancer Res; 1991 Oct; 51(20):5752-9. PubMed ID: 1655260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metaplasia of the duodenum shows a Helicobacter pylori-correlated differentiation into gastric-type protein expression.
    Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Dekker J
    Hum Pathol; 2003 Feb; 34(2):156-65. PubMed ID: 12612884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of pyloric gland-type mucin in mucin-producing bile duct carcinomas: a clear difference between the core peptide and the carbohydrate moiety.
    Goto M; Shibahara H; Tamada S; Hamada T; Oda K; Nagino M; Nagasaka T; Imai K; Nimura Y; Yonezawa S
    Pathol Int; 2005 Aug; 55(8):464-70. PubMed ID: 15998373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
    Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
    J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyloric gland adenoma: a histologic, immunohistochemical and molecular genetic study of 23 cases.
    Chlumská A; Waloschek T; Mukenšnabl P; Martínek P; Kašpírková J; Zámečník M
    Cesk Patol; 2015; 51(3):137-43. PubMed ID: 26421956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
    Warson C; Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Ectors NL; Dekker J
    Hum Pathol; 2002 Jun; 33(6):660-8. PubMed ID: 12152167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    J Pathol; 1998 Jun; 185(2):191-8. PubMed ID: 9713347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
    Zhao SM; Zhu XZ; Ji Y; Hou J
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers. II. A possible source of cholangiocarcinoma.
    Terada T; Nakanuma Y
    Hepatology; 1990 Jul; 12(1):92-7. PubMed ID: 2165033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of TFF2 and decreased αGlcNAc glycosylation are malignant biomarkers of pyloric gland adenoma of the duodenum.
    Yamanoi K; Fujii C; Nakayama A; Matsuura N; Takatori Y; Kato M; Yahagi N; Nakayama J
    Sci Rep; 2023 Dec; 13(1):21641. PubMed ID: 38062108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.